Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...
Egile Nagusiak: | Holyoake, D, Partridge, M, Hurt, C, Mukherjee, S, Hawkins, M |
---|---|
Formatua: | Conference item |
Argitaratua: |
Elsevier
2017
|
Antzeko izenburuak
-
Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
nork: Holyoake, DLP, et al.
Argitaratua: (2018) -
Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
nork: Holyoake, D, et al.
Argitaratua: (2016) -
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
nork: Holyoake, D, et al.
Argitaratua: (2017) -
Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
nork: Holyoake, D, et al.
Argitaratua: (2019) -
Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
nork: Holyoake, D, et al.
Argitaratua: (2018)